OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
ORGANIGRAM GLOBAL INC.
Financials through fiscal 2022, year ended Aug 31, 2022Last filing: 40-F on Dec 16, 2025
$0.94+0.02 (+1.73%)
Close on Oct 19, 2026
Organigram Global statistics
Financials through Aug 31, 2022, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Organigram Global | Industry median |
|---|---|---|
| Market Cap | C$180.87M | C$123.83M |
| Enterprise Value | C$181.10M | C$113.12M |
| PS Ratio | 1.24 | 1.24 |
Enterprise value
| Measure | Organigram Global | Industry median |
|---|---|---|
| EV / Sales | 1.24 | 1.14 |
Income (trailing twelve months)
| Measure | Organigram Global | Industry median |
|---|---|---|
| Revenue | C$145.81M | C$28.08M |
| Gross Profit | C$31.57M | C$13.09M |
| Operating Income | -C$43.15M | -C$11.94M |
| Pretax Income | -C$14.37M | -C$10.05M |
| EBITDA | -C$18.24M | -C$10.30M |
| EPS (Diluted) | -0.18 CAD | -0.14 CAD |
Margins
| Measure | Organigram Global | Industry median |
|---|---|---|
| Gross Margin | 21.7% | 41.6% |
| Operating Margin | -29.6% | -25.4% |
| Pretax Margin | -9.86% | -15.6% |
| EBITDA Margin | -12.5% | -16.8% |
| FCF Margin | -58.3% | -28.3% |
Returns
| Measure | Organigram Global | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -8.27% | -14.6% |
Growth
| Measure | Organigram Global | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 84.2% | 4.81% |
| Revenue Growth (3Y CAGR) | 21.9% | 8.51% |
Balance sheet
| Measure | Organigram Global | Industry median |
|---|---|---|
| Total Debt | C$235.00K | C$8.30M |
| Net Cash (Debt) | -C$235.00K | C$16.52M |
| Net Cash Per Share | -0.00 CAD | 0.25 CAD |
| Working Capital | C$166.34M | C$15.82M |
Financial position
| Measure | Organigram Global | Industry median |
|---|---|---|
| Current Ratio | 4.01 | 3.87 |
| Quick Ratio | 0.84 | 2.47 |
| Interest Coverage | -100.58 | -52.25 |
Cash flow (trailing twelve months)
| Measure | Organigram Global | Industry median |
|---|---|---|
| Operating Cash Flow | -C$36.21M | -C$6.28M |
| Capital Expenditures | -C$48.75M | -C$685.52K |
| Free Cash Flow | -C$84.96M | -C$10.42M |
| FCF Per Share | -0.63 CAD | -0.07 CAD |
Efficiency
| Measure | Organigram Global | Industry median |
|---|---|---|
| Asset Turnover | 0.26 | 0.44 |
| Inventory Turnover | 2.74 | 2.74 |
Dividends and yields
| Measure | Organigram Global | Industry median |
|---|---|---|
| FCF Yield | -47.0% | -10.0% |
| Buyback Yield | 0.00% | -3.22% |
| Shareholder Yield | 0.00% | -3.22% |
Shares
| Measure | Organigram Global | Industry median |
|---|---|---|
| Shares Outstanding | 134,461,000 | 74,643,400 |
| Shares Change (YoY) | 20.6% | 17.9% |
| Float | 92,229,900 | 74,292,200 |
| Shares Held by Insiders | 31.4% | 0.00% |
| Shares Held by Institutions | 5.66% | 7.94% |
Taxes
| Measure | Organigram Global | Industry median |
|---|---|---|
| Income Tax | -C$88.00K | C$0 |
Scores
| Measure | Organigram Global | Industry median |
|---|---|---|
| Altman Z-Score | 1.22 | 0.35 |
| Beneish M-Score | -2.80 |
Calculated by StockData from Organigram Global's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.